Prevalence of Cesarean Section Niche in Women With Unexplained Abnormal Uterine Bleeding (Niche)
Primary Purpose
Cesarean Section; Dehiscence, Abnormal Uterine Bleeding
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Office Hysteroscope
Sponsored by
About this trial
This is an interventional diagnostic trial for Cesarean Section; Dehiscence focused on measuring Hytsteroscopy
Eligibility Criteria
Inclusion Criteria:
Patients with a history of cesarean section who are complaining of abnormal uterine bleeding with the following criteria :
- Normal complete blood count apart from paramaters of anemia
- Not using drugs affecting coagulation profile
- Bleeding is not related to pregnancy
- Not using intrauterine contraceptive devices or hormonal contraceptives
- By ultrasonography : no abnormalities in the pelvis e.g benign or malignant tumors , ovarian cysts or tumors
- No evidence of cervical abnormalities as cause of bleeding with cervical examination or cervical smears
Exclusion Criteria:
- Any patient not fulfilling the inclusion criteria
- If the patient refused the technique ( office hysteroscopy )
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Office hysteroscopy
Arm Description
Examinatin with Office hysteroscope for women with abnormal uterine bleeding who had a history of previous cesarean section
Outcomes
Primary Outcome Measures
Prevalence of cisarean section niche
Prevalence of cisarean section niche in women complainig of unexplained abnormal uterine bleeding
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03130387
Brief Title
Prevalence of Cesarean Section Niche in Women With Unexplained Abnormal Uterine Bleeding
Acronym
Niche
Official Title
Prevalence of Cesarean Section Niche in Women With Unexplained Abnormal Uterine Bleeding
Study Type
Interventional
2. Study Status
Record Verification Date
April 2017
Overall Recruitment Status
Completed
Study Start Date
January 1, 2016 (Actual)
Primary Completion Date
April 20, 2017 (Actual)
Study Completion Date
April 20, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ain Shams University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Prevalence of Cesarean Section Niche in women With Unexplained Abnormal Uterine Bleeding
Detailed Description
Prevalence of Cesarean Section Niche as diagnosed by office hysteroscopy and transvaginal sonography in women With Unexplained Abnormal Uterine Bleeding
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cesarean Section; Dehiscence, Abnormal Uterine Bleeding
Keywords
Hytsteroscopy
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Hysteroscopic examination for patients with AUB
Masking
None (Open Label)
Allocation
N/A
Enrollment
95 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Office hysteroscopy
Arm Type
Other
Arm Description
Examinatin with Office hysteroscope for women with abnormal uterine bleeding who had a history of previous cesarean section
Intervention Type
Device
Intervention Name(s)
Office Hysteroscope
Intervention Description
Diagnosis of C.S niche in patients wit AUB by office hysteroscope
Primary Outcome Measure Information:
Title
Prevalence of cisarean section niche
Description
Prevalence of cisarean section niche in women complainig of unexplained abnormal uterine bleeding
Time Frame
1 year
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
Females only
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with a history of cesarean section who are complaining of abnormal uterine bleeding with the following criteria :
Normal complete blood count apart from paramaters of anemia
Not using drugs affecting coagulation profile
Bleeding is not related to pregnancy
Not using intrauterine contraceptive devices or hormonal contraceptives
By ultrasonography : no abnormalities in the pelvis e.g benign or malignant tumors , ovarian cysts or tumors
No evidence of cervical abnormalities as cause of bleeding with cervical examination or cervical smears
Exclusion Criteria:
Any patient not fulfilling the inclusion criteria
If the patient refused the technique ( office hysteroscopy )
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Prevalence of Cesarean Section Niche in Women With Unexplained Abnormal Uterine Bleeding
We'll reach out to this number within 24 hrs